Clinical Trials Browser

Recruiting × Metastatic Hormone-sensitive Prostate Cancer (mHSPC) × 90 days × Clear all

NCT07395804 2026-05-29

23146

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT06661122 2026-05-19

HAYATE

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT07241416 2026-05-11

A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Phase 3 Recruiting

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)